Background {#Sec1}
==========

Hemoptysis is a common complication in Cystic Fibrosis (CF) occurring in approximately 9% of patients.^[@CR1]^ The definition currently used for massive or major hemoptysis is acute bleeding of more than 240 ml/day or recurrent bleeding of substantial volumes over several days.^[@CR1],\ [@CR2]^ In the pediatric CF population it occurs in approximately 1 to 1.5% of cases and is a potentially life-threatening event.^[@CR1]^ Percutaneous bronchial artery embolization (BAE) is a safe and effective treatment in patients with major hemoptysis.^[@CR3]^ The CF Foundation guidelines support BAE for life-threatening hemoptysis without age limits.^[@CR2]^ Chest pain and dysphagia are commonly reported after BAE. Serious complications are rare; one of these being non-target vessel embolization with subsequent tissue ischemia.^[@CR3]^ We present a pediatric case of massive hemoptysis treated with BAE and complicated by unilateral diaphragmatic paralysis.

Case presentation {#Sec2}
=================

A female CF patient followed by the CF center of Florence had the first episode of hemoptysis at the age of 14 years. In the previous 2 years she suffered from chronic respiratory failure with a Forced Expiratory Volume in 1 s (FEV~1~) of 40--45% and chronic colonization by methicillin-resistant *Staphylococcus aureus* and intermittent colonization by *Pseudomonas aeruginosa*. At home, she presented low-grade fever, cough increase and two episodes of hemoptysis (\< 100 ml/day) treated initially with rest, minocycline and rifampicin administered orally. In the subsequent hours persisted others episodes of hemoptysis, and consequently she was referred to the Pediatric Emergency Department. On admission she was clinically stable. Intravenous antibiotic (linezolid and ceftazidime) were started. During the following 2 days she continued to have major hemorrhages (\> 200 ml/day). Computed tomographic angiography (CTA) of the chest did not show any active bleeding, although bronchial arteries were very tortuous and ectasic. The high risk of rebleeding, due to the severe vascular lung condition, led us to perform a percutaneous embolization. Selective bronchial angiography revealed the presence of a shunt between the right and left bronchial arteries. A super-selective catheterization of the right bronchial artery was achieved using a 2.4F microcatheter (Fig. [1](#Fig1){ref-type="fig"}a). Embolization was conducted using spherical microparticles (700--900 μm) until a "stop-flow" was evident in the distal segment of the artery. Fig. 1**a)** angiography of the main common bronchial artery, **b**) MIP coronal MDCT with elevated right hemidiaphragm and concomitant lung consolidation

No further episodes of hemoptysis were observed after BAE. However, within 24 h the patient started to complain of severe thoracic pain in the right hemithorax, increased dyspnea and fever. For these reasons, a CTA was repeated showing an elevated right hemidiaphragm, an area of consolidation in the lateral segment of the right lower lobe and a concomitant pleural effusion predominantly distributed in the inferior fissure (Fig. [1](#Fig1){ref-type="fig"}b)*.* A dynamic fluoroscopic evaluation confirmed the right diaphragmatic paralysis, not present before the procedure We changed the intravenous antibiotic therapy to piperacillin/tazobactam and tigecycline, administered corticosteroid i.v. and high flow oxygen by nasal cannula. After an initial phase of substantial instability, after 4 days the clinical condition and radiological imaging had improved with restored mobility of the right hemidiaphragm. Six months later, the trend of FEV~1~ had been reduced by 15 points compared with FEV~1~ pre-BAE and the patient was included on a waiting list for lung transplantation. Nine months later, she required mechanical ventilation, and subsequently the initiation of extracorporeal membrane oxygenation (ECMO) for a pulmonary exacerbation with septic shock. Lung transplantation in ECMO was performed with success.

Discussion and conclusions {#Sec3}
==========================

We report the first case of a pediatric CF patient with massive hemoptysis presenting a phrenic nerve injury following BAE. Similarly, Chapman et al. described a case of unilateral diaphragmatic paralysis following BAE in a 29 year-old woman due to a non-target embolization as the inadvertent obstruction of the pericardiacophrenic artery.^[@CR4]^ In our case the angiography did not show any connection of the right bronchial artery to other vessels (mammary artery, phrenic artery) or any connection to the circle of the phrenic nerve (Fig. [1](#Fig1){ref-type="fig"}a). However, we recommend the importance of considering acute pulmonary embolism in the patient's differential diagnosis.

Diaphragm dysfunction is typically due to phrenic nerve dysfunction, which can have various origins: malignancy infiltration, nerve lesion during thoracic surgery and diseases affecting peripheral or central nervous systems.^[@CR5]^ In many cases, isolated phrenic neuropathy with no apparent cause is categorized as idiopathic. Infectious processes have been proposed as the underlying cause.^[@CR5]^

Diaphragm dysfunction may be underdiagnosed, but it can negatively affect quality of life, can be a marker of disease severity and, in some instances, such as in the intensive care unit, be a prognostic marker.

BAE is undoubtedly a lifesaver procedure in massive hemoptysis, but it can lead to severe complications also in pediatric age. The risk/benefit ratio must be carefully evaluated. In particular, the end-stage CF can represent an important risk factor. Clinicians should be aware of the possibility of phrenic nerve injury with BAE monitoring the appearance of chest pain and dyspnea after the procedure since this complication is unpredictable and no special cares are known to avoid it.
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